Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management ; volume:143 ; number:3 ; year:2020 ; pages:217-231
Acta haematologica ; 143, Heft 3 (2020), 217-231
- Urheber
-
Saußele, Susanne
Haverkamp, Wilhelm
Lang, Fabian Magnus Eugen
Koschmieder, Steffen
Kiani, Alexander
Jentsch-Ullrich, Kathleen
Stegelmann, Frank
Pfeifer, Heike
La Rosée, Paul
Gökbuget, Nicola
Rieger, Christina
Waller, Cornelius F.
Franke, Georg-Nikolaus
le Coutre, Philipp
Kirchmair, Rudolf
Junghanß, Christian
- DOI
-
10.1159/000501927
- URN
-
urn:nbn:de:101:1-2020061800011889704442
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.04.2025, 08:13 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Saußele, Susanne
- Haverkamp, Wilhelm
- Lang, Fabian Magnus Eugen
- Koschmieder, Steffen
- Kiani, Alexander
- Jentsch-Ullrich, Kathleen
- Stegelmann, Frank
- Pfeifer, Heike
- La Rosée, Paul
- Gökbuget, Nicola
- Rieger, Christina
- Waller, Cornelius F.
- Franke, Georg-Nikolaus
- le Coutre, Philipp
- Kirchmair, Rudolf
- Junghanß, Christian
Ähnliche Objekte (12)
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms
Kidney dysfunction is associated with thrombosis and disease severity in myeloproliferative neoplasms: implications from the German study group for MPN bioregistry
Novel approaches in myelofibrosis
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German Expert Consensus Panel with focus on cardiovascular management
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management
Ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute leukemia: recommendations of a German expert consensus panel with focus on cardiovascular management
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Diagnostik und Therapie der Polycythaemia vera im Jahre 2015
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia
Molekular zielgerichtete Therapie der chronischen myeloischen Leukämie (CML)
Elucidating the complexity of the interferon alpha response and clonal heterogeneity in polycythemia vera patients using single-cell RNA sequencing
Influence of the JAK2-V617F mutation on integrin-mediated adhesion to VCAM1 in murine and human cell lines in the context of classical Philadelphia-negative myeloproliferative neoplasms